Cargando…

Metastatic Breast Cancer Survival according to HER2 and Topo2a Gene Status

The aim of this study was to determine the relationship between amplification of HER2 (Human epidermal growth factor receptor 2) and Topo2a (topoisomerase 2a) and their influence on prognosis in metastatic breast cancer (MBC) patients. Amplification of both HER2 and Topo2a genes was determined by ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Todorović-Raković, N., Nešković-Konstantinović, Z., Nikolić-Vukosavljević, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833411/ https://www.ncbi.nlm.nih.gov/pubmed/19729798 http://dx.doi.org/10.3233/DMA-2009-0628

Ejemplares similares

The antitumor immune response in HER-2 positive, metastatic breast cancer patients
por: Juranic, Zorica D, et al.
Publicado: (2005)

Trefoil Factor 1 in Early Breast Carcinoma: A Potential Indicator of Clinical Outcome during the First 3 Years of Follow-Up
por: Markićević, Milan, et al.
Publicado: (2014)

Immunohistochemiluminescence Detection: A Quantitative Tool in Breast Cancer HER-2 Status Evaluation
por: Rêgo, Moacyr Jesus Barreto de Melo, et al.
Publicado: (2013)

Comparison between Real-Time Quantitative PCR Detection of HER2 mRNA Copy Number in Peripheral Blood and ELISA of Serum HER2 Protein for Determining HER2 Status in Breast Cancer Patients
por: Savino, Maria, et al.
Publicado: (2009)

El topo
por: Le Carré, John, 1931-

Higher Topos Theory
por: Lurie, Jacob
Publicado: (2009)

Higher topos theory
por: Lurie, Jacob
Publicado: (2009)

El Viejo topo.
Publicado: (1981)

Topo II on the move?
por: LeBrasseur, Nicole
Publicado: (2002)

HER1 R497K and HER2 I655V Polymorphisms Are Linked to Development of Breast Cancer
por: AbdRaboh, Naglaa R., et al.
Publicado: (2013)

Impact of Her-2 Overexpression on Survival of Patients with Metastatic Breast Cancer
por: dos Santos, Giovana Tavares, et al.
Publicado: (2017)

Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors
por: Palm, Christiane, et al.
Publicado: (2023)

Validation of a Fully Automated HER2 Staining Kit in Breast Cancer
por: Moelans, Cathy B., et al.
Publicado: (2010)

Expression Profile of Tyrosine Phosphatases in HER2 Breast Cancer Cells and Tumors
por: Lucci, Maria Antonietta, et al.
Publicado: (2010)

El topo : las películas de Alejandro Jodorowsky
Publicado: (2007)

Educar a los topos
por: Fadanelli, Guillermo J.

Evolution and Diversity of the TopoVI and TopoVI-like Subunits With Extensive Divergence of the TOPOVIBL subunit
por: Brinkmeier, Julia, et al.
Publicado: (2022)

Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis
por: Honkanen, Tiia J., et al.
Publicado: (2021)

Clinical outcome of adjuvant endocrine treatment according to Her-2/neu status in breast cancer
por: James, Rani, et al.
Publicado: (2011)

HER2-targeted therapy influences CTC status in metastatic breast cancer
por: Deutsch, Thomas M., et al.
Publicado: (2020)

Topo/grafías : literatura y región : el caso de Bogotá
por: Acosta Peñaloza, Carmen Elisa
Publicado: (2016)

HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status
por: Weitsman, Gregory, et al.
Publicado: (2016)

Single-nucleotide resolution detection of Topo IV cleavage activity in the Escherichia coli genome with Topo-Seq
por: Sutormin, Dmitry, et al.
Publicado: (2023)

Potential Multifunctional Bioactive Compounds from Dysosma versipellis Explored by Bioaffinity Ultrafiltration-HPLC/MS with Topo I, Topo II, COX-2 and ACE2
por: Feng, Huixia, et al.
Publicado: (2022)

Pyrotinib Improves Survival in Previously Treated HER2-Positive Metastatic Breast Cancer
por: Jacobson, Anne
Publicado: (2022)

Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report
por: Gluz, Oleg, et al.
Publicado: (2020)

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
por: Mendes, Diogo, et al.
Publicado: (2015)

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
por: Chen, I-Chun, et al.
Publicado: (2021)

Between immunomodulation and immunotolerance: The role of IFNγ in SARS-CoV-2 disease
por: Todorović-Raković, Nataša, et al.
Publicado: (2021)

A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
por: Yang, Yuqin, et al.
Publicado: (2022)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

Topo2008: DNA Topoisomerases in Biology and Medicine
por: Maxwell, Tony, et al.
Publicado: (2009)

A second course in topos quantum theory
por: Flori, Cecilia
Publicado: (2018)

A first course in topos quantum theory
por: Flori, Cecilia
Publicado: (2013)

Sketches of an elephant: a Topos theory compendium
por: Johnstone, Peter T
Publicado: (2002)

The role of her2-targeted therapies in women with her2-overexpressing metastatic breast cancer
por: Dent, S., et al.
Publicado: (2009)

Expression of HER2 in Colorectal Cancer Does Not Correlate with Prognosis
por: Kruszewski, Wiesław Janusz, et al.
Publicado: (2010)

HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
por: Moelans, Cathy B., et al.
Publicado: (2009)

Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
por: Yang, Liu, et al.
Publicado: (2022)

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
por: Hosonaga, Mari, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7ijaaplrbi1l9ub37pq58b9sb3